Cash Flow from Financial Activities (Quarterly)

Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.

Novartis AG (NVS) had Cash Flow from Financial Activities of $-5.16B for the most recently reported fiscal quarter, ending 2024-03-31.

Quarterly Annual

Figures for fiscal quarter ending 2024-03-31

Income Statement Financials
Revenue	$12.12B
Net Income	$2.69B
Cost of Goods Sold	$3.10B
Gross Profit	$9.02B
Operating Expenses	$8.75B
Operating Income	$3.37B
Non-Operating Income/Expense	$-244.00M
Pre-Tax Income	$3.13B
Normalized Pre-Tax Income	$3.13B
Income after Taxes	$2.69B
Income from Continuous Operations	$2.69B
Consolidated Net Income/Loss	$2.69B
Normalized Income after Taxes	$2.69B
EBIT	$3.37B
EBITDA	$4.71B
Weighted-Average Shares Outstanding (Basic)	2.04B
Weighted-Average Shares Outstanding (Diluted)	2.06B
Earnings per Share (EPS) (Basic)	$1.31
Earnings per Share (EPS) (Diluted)	$1.31
Balance Sheet Financials
Current Assets	$26.45B
Property, Plant, and Equipment	$9.20B
Long-Term Assets	$67.89B
Total Assets	$94.33B
Current Liabilities	$29.29B
Long-Term Debt	$17.19B
Long-Term Liabilities	$25.29B
Total Liabilities	$54.58B
Common Equity	$39.76B
Tangible Shareholders Equity	$-9.58B
Shareholders Equity	$39.76B
Common Shares Outstanding	2.04B
Cash Flow Statement Financials
Cash Flow from Operating Activities	$2.27B
Cash Flow from Investing Activities	$-899.00M
Cash Flow from Financial Activities	$-5.16B
Beginning Cash	$13.39B
End Cash	$9.47B
Increase/Decrease in Cash	$-3.92B
Stock-Based Compensation	$260.00M
Common Stock Dividends Paid	$-5.21B
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	0.90
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.30
Debt to Equity Ratio	0.64
Gross Margin	74.46%
Operating Margin	27.83%
EBIT Margin	27.83%
EBITDA Margin	--
Pre-Tax Profit Margin	25.82%
Profit Margin	22.18%
Free Cash Flow	$2.04B
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.13
Inventory Turnover	0.54
Receiveable Turnover	1.47
Days Sales in Receivables	61.27
Return on Equity	6.76%
Return on Tangible Equity	-28.06%
Return on Assets	2.85%
Return on Investments	4.72%
Book Value Per Share	$19.48
Free Cash Flow per Share	$0.99
Operating Cash Flow per Share	$1.10

Data from Zacks Investment Research, Inc.